Gibson Christopher sold RXRX
January 5, 2026 · Form 4 insider transaction
Gibson Christopher sold 20,000 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as gift under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
20,000
Price
$0.00
Total value
N/A
InsiderGibson Christopher
Role—
SecurityClass A Common Stock
Transaction codeG: Gift
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after913,839
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.